Cardiolipin fingerprinting of leukocytes by MALDI-TOF/MS as a screening tool for Barth syndrome

Journal of Lipid Research

Volumn 56, Issue 9, 2015, Pages 1787-1794

  Angelini, Roberto ^a   Lobasso, Simona ^a   Gorgoglione, Ruggiero ^a   Bowron, Ann ^b   Steward, Colin G ^c   Corcelli, Angela ^a  

^a UNIVERSITY OF BARI   (Italy)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

cardiomyopathy; Lysophospholipids; Mass spectrometry; Matrix assisted laser desorption ionization; Mitochondria; Phospholipids; Phospholipids metabolism; Tafazzin; Time of flight

Indexed keywords

CARDIOLIPIN; FATTY ACID; LINOLEOYL; OLEOYL; TETRALINOLEOYL; UNCLASSIFIED DRUG; LYSOPHOSPHOLIPID; PHOSPHOLIPID;

ADULT; ARTICLE; BARTH SYNDROME; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GENE MUTATION; HUMAN; HUMAN CELL; LEUKOCYTE; LIPID ANALYSIS; LIPID COMPOSITION; MALE; MASS SPECTROMETRY; MATHEMATICAL ANALYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TAZ GENE; VECTOR ALGEBRA; BIOSYNTHESIS; BLOOD; CARDIOMYOPATHY; DNA FINGERPRINTING; GENETICS; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; MITOCHONDRION; MUTATION; NORMAL HUMAN; PATHOLOGY;

ADULT; BARTH SYNDROME; CARDIOLIPINS; CARDIOMYOPATHIES; DNA FINGERPRINTING; HEALTHY VOLUNTEERS; HUMANS; LEUKOCYTES; LYSOPHOSPHOLIPIDS; MALE; MITOCHONDRIA; MUTATION; PHOSPHOLIPIDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84941011911     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D059824     Document Type: Article

References (38)

1. Steward, C. G., R. P. Martin, A. M. Hayes, A. P. Salmon, M. M. Williams, L. A. Tyfield, S. J. Davies, and R. A. Newbury-Ecob. 2004. Barth syndrome (X linked cardiac and skeletal myopathy, neutropenia, and organic aciduria): rarely recognised, frequently fatal [abstract]. Arch. Dis. Child. 89: A48. Abstract G140.
2. Barth, P. G., H. R. Scholte, J. A. Berden, J. M. Van der Klei-Van Moorsel, I. E. Luyt-Houwen, E. T. Van 't Veer-Korthof, J. J. Van der Harten, and M. A. Sobotka-Plojhar. 1983. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J. Neurol. Sci. 62: 327-355.
3. Barth, P. G., C. Van den Bogert, P. A. Bolhuis, H. R. Scholte, A. H. van Gennip, R. B. Schutgens, and A. G. Ketel. 1996. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): respiratory-chain abnormalities in cultured fibroblasts. J. Inherit. Metab. Dis. 19: 157-160.
4. Clarke, S. L., A. Bowron, I. L. Gonzalez, S. J. Groves, R. Newbury-Ecob, N. Clayton, R. P. Martin, B. Tsai-Goodman, V. Garratt, M. Ashworth, et al. 2013. Barth syndrome. Orphanet J. Rare Dis. 8: 23.
5. Whited, K., M. G. Baile, P. Currier, and S. M. Claypool. 2013. Seven functional classes of Barth Syndrome mutation. Hum. Mol. Genet. 22: 483-492.
6. Vreken, P., F. Valianpour, L. G. Nijtmans, L. A. Grivell, B. Plecko, R. J. Wanders, and P. G. Barth. 2000. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279: 378-382.
7. Schlame, M., and M. Ren. 2006. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett. 580: 5450-5455.
8. Mileykovskaya, E., and W. Dowhan. 2009. Cardiolipin membrane domains in prokaryotes and eukaryotes. Biochim. Biophys. Acta. 1788: 2084-2091.
9. Claypool, S. M., and C. M. Koehler. 2012. The complexity of cardiolipin in health and disease. Trends Biochem. Sci. 37: 32-41.
10. Schlame, M., D. Rua, and M. L. Greenberg. 2000. The biosynthesis and functional role of cardiolipin. Prog. Lipid Res. 39: 257-288.
11. Gohil, V. M., P. Hayes, S. Matsuyama, H. Schägger, M. Schlame, and M. L. Greenberg. 2004. Cardiolipin biosynthesis and mitochondrial respiratory chain function are interdependent. J. Biol. Chem. 279: 42612-42618.
12. Haines, T. H., and N. A. Dencher. 2002. Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett. 528: 35-39.
13. Pfeiffer, K., V. Gohil, R. A. Stuart, C. Hunte, U. Brandt, M. L. Greenberg, and H. Schagger. 2003. Cardiolipin stabilizes respiratory chain supercomplexes. J. Biol. Chem. 278: 52873-52880.
14. Claypool, S. M., P. Boontheung, J. M. McCaffery, J. A. Loo, and C. M. Koehler. 2008. The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome. Mol. Biol. Cell. 19: 5143-5155.
15. Xu, F. Y., H. McBride, D. Acehan, F. M. Vaz, R. H. Houtkooper, R. M. Lee, M. A. Mowat, and G. M. Hatch. 2010. The dynamics of cardiolipin synthesis post mitochondrial fusion. Biochim. Biophys. Acta. 1798: 1577-1585.
16. Kagan, V. E., C. T. Chu, Y. Y. Tyurina, A. Cheikhi, and H. Bayir. 2014. Cardiolipin asymmetry, oxidation and signaling. Chem. Phys. Lipids. 179: 64-69.
17. Nugent, A. W., P. E. Daubeney, P. Chondros, J. B. Carlin, M. Cheung, L. C. Wilkinson, A. M. Davis, S. G. Kahler, C. W. Chow, J. L. Wilkinson, et al. 2003. The epidemiology of childhood cardiomyopathy in Australia. N. Engl. J. Med. 348: 1639-1646.
18. Xu, Y., J. J. Sutachan, H. Plesken, R. I. Kelley, and M. Schlame. 2005. Characterization of lymphoblast mitochondria from patients with Barth syndrome. Lab. Invest. 85: 823-830.
19. Houtkooper, R. H., R. J. Rodenburg, C. Thiels, H. van Lenthe, F. Stet, B. T. Poll-The, J. E. Stone, C. G. Steward, R. J. Wanders, J. Smeitink, et al. 2009. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome. Anal. Biochem. 387: 230-237.
20. Valianpour, F., R. J. Wanders, P. G. Barth, H. Overmars, and A. H. van Gennip. 2002. Quantitative and compositional study of cardiolipin in platelets by electrospray ionization mass spectrometry: application for the identification of Barth syndrome patients. Clin. Chem. 48: 1390-1397.
21. Schlame, M., J. A. Towbin, P. M. Heerdt, R. Jehle, S. Di Mauro, and T. J. Blanck. 2002. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann. Neurol. 51: 634-637.
22. Schlame, M., R. I. Kelley, A. Feigenbaum, J. A. Towbin, P. M. Heerdt, T. Schieble, R. J. Wanders, S. DiMauro, and T. J. Blanck. 2003. Phospholipid abnormalities in children with Barth syndrome. J. Am. Coll. Cardiol. 42: 1994-1999.
23. Valianpour, F., R. J. Wanders, H. Overmars, P. Vreken, A. H. Van Gennip, F. Baas, B. Plecko, R. Santer, K. Becker, and P. G. Barth. 2002. Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts. J. Pediatr. 141: 729-733.
24. van Werkhoven, M. A., D. R. Thorburn, A. K. Gedeon, and J. J. Pitt. 2006. Monolysocardiolipin in cultured fibroblasts is a sensitive and specific marker for Barth Syndrome. J. Lipid Res. 47: 2346-2351.
25. Kuijpers, T. W., N. A. Maianski, A. T. Tool, K. Becker, B. Plecko, F. Valianpour, R. J. Wanders, R. Pereira, J. Van Hove, A. J. Verhoeven, et al. 2004. Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood. 103: 3915-3923.
26. Bowron, A., R. Frost, V. E. C. Powers, P. H. Thomas, S. J. R. Heales, and C. G. Steward. 2013. Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis. J. Inherit. Metab. Dis. 36: 741-746.
27. Kulik, W., H. van Lenthe, F. S. Stet, R. H. Houtkooper, H. Kemp, J. E. Stone, C. G. Steward, R. J. Wanders, and F. M. Vaz. 2008. Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome. Clin. Chem. 54: 371-378.
28. Schiller, J., R. Suss, B. Fuchs, M. Muller, O. Zschornig, and K. Arnold. 2007. MALDI-TOF MS in lipidomics. Front. Biosci. 12: 2568-2579.
29. Sun, G., Z. Yang, S. Zhao, X. Guan, R. Han, and W. Gross. 2008. Matrix assisted laser desorption/ionization time-of-flight mass spectrometric analysis of cellular glycerophospholipids enabled by multiplexed solvent dependent analyte-matrix interactions. Anal. Chem. 80: 7576-7585.
30. Angelini, R., F. Babudri, S. Lobasso, and A. Corcelli. 2010. MALDI-TOF/MS analysis of archaebacterial lipids in lyophilized membranes dry-mixed with 9-aminoacridine. J. Lipid Res. 51: 2818-2825.
31. Angelini, R., R. Vitale, V. A. Patil, T. Cocco, B. Ludwig, M. L. Greenberg, and A. Corcelli. 2012. Lipidomics of intact mitochondria by MALDI-TOF MS. J. Lipid Res. 53: 1417-1425.
32. Angelini, R., G. Vormieter, A. Corcelli, and B. Fuchs. 2014. A fast method for the determination of PC/LPC ratio in intact horse serum by MALDI-TOF-MS: an easy-to-follow lipid biomarker of inflammation. Chem. Phys. Lipids. 183: 169-175.
33. Vitale, R., R. Angelini, S. Lobasso, G. Capitanio, B. Ludwig, and A. Corcelli. 2015. MALDI-TOF MS lipid profiles of cytochrome c oxidases: cardiolipin is not an essential component of the Paracoccus denitrificans oxidase. Biochemistry. 54: 1144-1150.
34. Schlame, M., S. Blais, I. Edelman-Novemsky, Y. Xu, F. Montecillo, C. K. Phoon, M. Ren, and T. A. Neubert. 2012. Comparison of cardiolipins from Drosophila strains with mutations in putative remodeling enzymes. Chem. Phys. Lipids. 165: 512-519.
35. Bowron, A., J. Honeychurch, M. Williams, B. Tsai-Goodman, N. Clayton, L. Jones, G. J. Shortland, S. A. Qureshi, S. J. Heales, and C. G. Steward. 2015. Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype. J. Inherit. Metab. Dis. 38: 279-286.
36. Ferri, L., M. A. Donati, S. Funghini, S. Malvagia, S. Catarzi, L. Lugli, L. Ragni, E. Bertini, F. M. Vaz, D. N. Cooper, et al. 2013. New clinical and molecular insights on Barth syndrome. Orphanet J. Rare Dis. 8: 27.
37. Han, X., and R. W. Gross. 2005. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom. Rev. 24: 367-412.
38. Kiebish, M. A., K. Yang, X. Liu, D. J. Mancuso, S. Guan, Z. Zhao, H. F. Sims, R. Cerqua, T. W. Cade, X. Han, et al. 2013. Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome. J. Lipid Res. 54: 1312-1325.